Leishmaniasis in Sudan. Visceral leishmaniasis (Q40602460)

21 September 2017

Leishmaniasis in Sudan. Visceral leishmaniasis (English)

1 reference

21 September 2017

0 references

visceral leishmaniasis

1 reference

Zijlstra EE

1

1 reference

PubMed ID

11370250

21 September 2017

el-Hassan AM

series ordinal

2

1 reference

21 September 2017

1 April 2001

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

21 September 2017

1 reference

21 September 2017

95 Suppl 1

1 reference

21 September 2017

S27-58

1 reference

Cutaneous leishmaniasis in the Sudan

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

The relationship between human and animal strains of Leishmania from the Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Comparison of two dosage schedules of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Epidemic visceral leishmaniasis in southern Sudan: identity and systematic position of the parasites from patients and vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

A prospective study of visceral leishmaniasis in an endemic area of Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

rK39: A Cloned Antigen of Leishmania chagasi that Predicts Active Visceral Leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Multi-centre evaluation of repeatability and reproducibility of the direct agglutination test for visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Outbreak of kala-azar in the Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Leishmaniasis. Public health aspects and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Liver morphology and function in visceral leishmaniasis (Kala-azar)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Post-kala-azar dermal leishmaniasis in the absence of active visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Kala-azar in western Upper Nile province in the southern Sudan and its spread to a nomadic tribe from the north

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Phlebotomine sandflies in a focus of visceral leishmaniasis in a border area of eastern Sudan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Infection rates of Leishmania donovani in Phlebotomus orientalis from a focus of visceral leishmaniasis in eastern Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Environmental determinants of the distribution of Phlebotomus orientalis in Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

A comparison of the direct agglutination test and enzyme-linked immunosorbent assay in the sero-diagnosis of leishmaniasis in the Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Studies on the leishmaniases in the Sudan. 3. Clinical and parasitological studies on visceral and mucosal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Clinical and immunological responses following accidental inoculation of Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Epidemiology of visceral leishmaniasis in northeast Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Leishmanial cholecystitis and colitis in a patient with visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Interleukin 10 production correlates with pathology in human Leishmania donovani infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

An outbreak of acute kala-azar in a nomadic tribe in western Sudan: features of the disease in a previously non-immune population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Prevalence and disease spectrum in a new focus of visceral leishmaniasis in Kenya.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Leishmania resistant to sodium stibogluconate: drug-associated macrophage-dependent killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Diversity among Leishmania isolates from the Sudan: isoenzyme homogeneity of L. donovani versus heterogeneity of L. major

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Serodiagnosis of Leishmania donovani infections: assessment of enzyme-linked immunosorbent assays using recombinant L. donovani gene B protein (GBP) and a peptide sequence of L. donovani GBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: management of those who do not respond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Kala-azar: liver fine needle aspiration findings in 23 cases presenting with a fever of unknown origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Phlebotomus martini--a probable vector of kala-azar in Kenya.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Amphotericin B for second-line treatment of Indian kala-azar

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

A latex agglutination test for the serodiagnosis of visceral leishmaniasis in Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Congenital visceral leishmaniasis: case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Biochemical and molecular characterization of Leishmania parasites isolated from an endemic focus in eastern Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Use of PCR on lymph-node sample as test of cure of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Use of the polymerase chain reaction to assess the success of visceral leishmaniasis treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Visceral leishmaniasis in southern Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Serum erythropoietin concentration in anaemia of visceral leishmaniasis (kala-azar) before and during antimonial therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Incrimination of Phlebotomus (Larroussius) orientalis as a vector of visceral leishmaniasis in western Upper Nile Province, southern Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Epidemic visceral leishmaniasis in southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Antibody responses of visceral leishmaniasis patients to gp63, a major surface glycoprotein of Leishmania species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Editorial: Measurement of delayed skin-test responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Rapid accurate field diagnosis of Indian visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Trial of oral miltefosine for visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Towards a kala azar risk map for Sudan: mapping the potential distribution of Phlebotomus orientalis using digital data of environmental variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Interleukin 6 during active visceral leishmaniasis and after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

SEROLOGICAL AND SKIN TEST SURVEY IN A VILLAGE OF CENTRAL SUDAN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Leishmaniasis and malaria: DNA probes for diagnosis and epidemiologic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Direct agglutination test for diagnosis and sero-epidemiological survey of kala-azar in the Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Soluble receptors for tumor necrosis factor as markers of disease activity in visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

The direct agglutination test for diagnosis of visceral leishmaniasis under field conditions in Sudan: comparison of aqueous and freeze-dried antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Random amplified polymorphic DNA for the differentiation of Leishmania donovani isolates from Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Ketoconazole in treatment of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Ketoconazole in visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

The use of DNA probes in the identification of leishmanias: discrimination between isolates of the Leishmania mexicana and L. braziliensis complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Operational validation of the direct agglutination test for diagnosis of visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

LEISHMANIASIS IN THE SUDAN REPUBLIC. XXI. INFECTION IN AMERICAN PERSONNEL.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Activation of latent kala-azar and malaria by battle experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome)

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Serodiagnosis of Sudanese visceral and mucosal leishmaniasis: comparison of ELISA--immunofluorescence and indirect haemagglutination

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Post-kala-azar anterior uveitis: demonstration of Leishmania parasites in the lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Identification of Leishmania donovani using a polymerase chain reaction in patient and animal material obtained from an area of endemic kala-azar in the Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Post kala-azar ocular leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Northward spread of visceral leishmaniasis in the Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Reciprocal relationships between undernutrition and the parasitic disease visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Tinea versicolor and visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Comparative merits of sternum, spleen and liver punctures in the study of human visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

The polymerase chain reaction can reveal the occurrence of naturally mixed infections with Leishmania parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Kala-azar in a high transmission focus: an ethnic and geographic dimension.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Studies in leishmaniasis in the Anglo-Egyptian Sudan. XII. Attempts to find a reservoir host

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Studies in leishmaniasis in the anglo-EGyptian Sudan. XI. Phlebotomus in relation to leishmaniasis in the Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

An Unusual Case of Leishmaniasis Treated with 4:4′-Diamidino Diphenoxy Pentane

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

The Use of Certain Aromatic Diamidines in the Treatment of Kala-Azar

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Leishmania in the Old World: 4. The distribution of L. donovani sensu lato zymodemes

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Comparison of microscopy and culture in the detection of Leishmania donovani from splenic aspirates

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Leishmaniasis in the Sudan Republic. 22. Leishmania hoogstraali sp. n. in the Gecko

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

An easy and quick method for the diagnosis of visceral leishmaniasis in HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

The role of fat-storing cells in Disse space fibrogenesis in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Jejunal function and pathology in visceral Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Successful chemotherapy in experimental leishmaniasis is influenced by the polarity of the T cell response before treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

"Leishmania Donovani" in the Soudan.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Diagnosis of symptomatic visceral leishmaniasis by use of the polymerase chain reaction on patient blood

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Studies on mediterranean Leishmaniasis. I. An outbreak of visceral leishmaniasis in Northern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Migration of Leishmania donovani amastigotes in the cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

A Peculiar Intralobular Cirrhosis of the Liver Produced by the Protozoal Parasite of Kala-Azar

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

LEISHMANIASIS IN THE SUDAN REPUBLIC. XVIII. PARASITEMIA IN KALA-AZAR.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Antimony Treatment of Sudan Kala-Azar

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

A NEW EXPERIMENTAL HOST OF LEISHMANIA DONOVANI

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Leishmanial excreted factor (EF) serotypes in Sudan, Kenya and Ethiopia.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

The biochemical and serological taxonomy of visceralizingLeishmania

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Leishmania braziliensis braziliensis isolated from Akodon arviculoides captured in Caratinga, Minas Gerais, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

An Epidemic of Kala-Azar in the Upper Nile Province of the Anglo-Egyptian Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Treatment of kala-azar with oral fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Atovaquone alone or with fluconazole as oral therapy for Indian kala-azar

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Leishmaniasis acquired by contagion: a case of marital infection in Britain

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Laboratory infection with Leishmania donovani; a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Sodium antimony gluconate, amphotericin, and myocardial damage

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

1 reference

7 January 2021

The treatment of kala-azar in the Sudan with sodium stibogluconate: a randomized trial of three dosage regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Serodiagnosis of visceral leishmaniasis in an endemic area of the Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Visceral leishmaniasis in Sudan. A delayed development disaster?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

The biochemical and serological taxonomy of Leishmania from the Aethiopian zoogeographical region of Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Parasitic culture of buffy coat for diagnosis of visceral leishmaniasis in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Laryngeal involvement during post kala-azar dermal leishmaniasis in India

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Hepatic fibrin-ring granulomas in a patient with hepatitis A.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

Visceral leishmaniasis in southern Sudan: status of healthy villagers in epidemic conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990218-4

7 January 2021

10.1016/S0035-9203(01)90218-4

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

11370250